<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Devonian Health Group provides more details on Previously Announced Positive Topline Results from Phase 2 Clinical trial of Thykamine™ in Adult Population with Mild-to-Moderate Atopic Dermatitis and the Grant of Stock Options	</title>
	<atom:link href="https://groupedevonian.com/devonian-health-group-provides-more-details-on-previously-announced-positive-topline-results-from-phase-2-clinical-trial-of-thykamine-in-adult-population-with-mild-to-moderate-atopic-dermatit/feed/" rel="self" type="application/rss+xml" />
	<link>https://groupedevonian.com/devonian-health-group-provides-more-details-on-previously-announced-positive-topline-results-from-phase-2-clinical-trial-of-thykamine-in-adult-population-with-mild-to-moderate-atopic-dermatit/</link>
	<description>Botanical pharmaceutical corporation</description>
	<lastBuildDate>Fri, 05 Jan 2024 15:06:26 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	
</channel>
</rss>
